This move is archived. Current quotes and coverage live on the stock page.
Get MBX alerts:
Microbix Biosystems Inc. is facing a notable decline in its stock price, raising concerns among investors.
Microbix Biosystems Inc. (MBX.TO) is experiencing a downturn, with its stock dropping by 1.72% in today's trading session, closing at CA$0.28. This decline highlights ongoing challenges for the company as it navigates a competitive landscape and recent operational setbacks.
Investor takeaway: Investors should be cautious as Microbix's stock struggles to maintain upward momentum amidst a backdrop of financial instability and operational challenges.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$42.46M
52W high
$0.33
52W low
$0.21
1W change
+5.08%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX · as of Sep 17, 2026
Wall Street analysts forecast MBX stock price to rise 29.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+29.0% Upside
Current Price
C$0.31
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
58.9%
Annualized
90-Day Vol
54.2%
Annualized
Trend (90d)
+13.8%
Annualized drift
90d Mean
C$0.33
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.32 | C$0.26 – C$0.39 |
| 60 trading days | C$0.32 | C$0.24 – C$0.43 |
| 90 trading days | C$0.33 | C$0.23 – C$0.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Market Cap: CA$39.2 Million
With a market cap of CA$39.2 million, Microbix remains a small player in the biotech sector, which can lead to higher volatility and risk for investors.
Bull case
Despite the recent challenges, Microbix has shown some resilience, reporting a 17% revenue growth in Q3 fiscal 2026 compared to the previous year. This suggests there is potential for recovery ahead.
Bear case
The current decline in the company's stock reflects ongoing operational issues and a lack of recent positive news. This situation may continue to weigh on investor sentiment and stock performance.
Current Stock Performance
Advertisement
Microbix Biosystems Inc. saw its stock price decrease by 1.72% today, closing at CA$0.28. This decline is part of a broader trend as the company grapples with financial challenges and investor skepticism.
Recent Company Developments
While Microbix reported a 17% revenue growth in its latest quarterly results, the absence of recent positive news may have contributed to today's stock performance. Investors are closely monitoring the company's ability to sustain growth and address operational hurdles.
Investor Sentiment
With a market cap of CA$39.2 million, Microbix's stock remains susceptible to volatility. Investors should weigh the recent performance and the company's operational challenges before making decisions. For more insights, check out the latest updates on Microbix Biosystems Inc..
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
